Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	protein serine kinase activity	LRRK2 PBK CDK14 NEK4 DCLK2 WNK3 MOS STK31 PIKFYVE CSNK1D CSNK1E PRKACB PRKG1	5.24e-05	363	192	13	GO:0106310
GeneOntologyMolecularFunction	calcium ion binding	CAPN9 TRPM4 NCL DYSF ITPR1 OTOF PLCB3 FER1L5 PLSCR1 SELL PCDHGB3 ANXA6 ANXA11 CLSTN1 CRB1 EDEM2 ATP2A2 AGRN CDH17	1.17e-04	749	192	19	GO:0005509
GeneOntologyMolecularFunction	cytoskeletal protein binding	TPM1 TPM2 MAGI1 CTNNAL1 DCDC1 LRRK2 RABGAP1 DYSF MTUS1 CLTC DIAPH2 DCLK2 CAP1 CACNA1C DSTN VEZT SYNE1 CLSTN1 KIF20B TUBGCP6 XIRP2 EPB41 TTLL13 MYBPC1	1.49e-04	1099	192	24	GO:0008092
GeneOntologyMolecularFunction	kinase activity	EPHB3 MATK LRRK2 PBK CDK14 PGK2 NEK4 DCLK2 WNK3 MOS BAZ1B HKDC1 STK31 PIKFYVE CSNK1D CSNK1E PRKACB CARD11 PRKG1	1.51e-04	764	192	19	GO:0016301
GeneOntologyMolecularFunction	protein kinase activity	EPHB3 MATK LRRK2 PBK CDK14 NEK4 DCLK2 WNK3 MOS BAZ1B STK31 PIKFYVE CSNK1D CSNK1E PRKACB PRKG1	2.35e-04	600	192	16	GO:0004672
GeneOntologyMolecularFunction	transferase activity, transferring phosphorus-containing groups	EPHB3 MATK LRRK2 PBK CDK14 PGK2 NEK4 DCLK2 WNK3 MOS POLE BAZ1B HKDC1 STK31 POLR3A PIKFYVE CSNK1D CSNK1E PRKACB CARD11 PRKG1	2.84e-04	938	192	21	GO:0016772
GeneOntologyMolecularFunction	protein serine/threonine kinase activity	LRRK2 PBK CDK14 NEK4 DCLK2 WNK3 MOS STK31 PIKFYVE CSNK1D CSNK1E PRKACB PRKG1	3.97e-04	446	192	13	GO:0004674
GeneOntologyMolecularFunction	phosphotransferase activity, alcohol group as acceptor	EPHB3 MATK LRRK2 PBK CDK14 NEK4 DCLK2 WNK3 MOS BAZ1B HKDC1 STK31 PIKFYVE CSNK1D CSNK1E PRKACB PRKG1	5.13e-04	709	192	17	GO:0016773
GeneOntologyMolecularFunction	calcium ion transmembrane transporter activity	TRPM4 ITPR1 GPM6A CACNA1C CACNA2D4 ATP2A2 ATP2A3	6.56e-04	151	192	7	GO:0015085
GeneOntologyCellularComponent	platelet dense tubular network membrane	ITPR1 ATP2A2 ATP2A3	6.15e-05	9	192	3	GO:0031095
GeneOntologyCellularComponent	platelet dense tubular network	ITPR1 ATP2A2 ATP2A3	1.19e-04	11	192	3	GO:0031094
Domain	FerI	DYSF OTOF FER1L5	1.09e-05	5	194	3	SM01202
Domain	FerB	DYSF OTOF FER1L5	1.09e-05	5	194	3	SM01201
Domain	Ferlin_B-domain	DYSF OTOF FER1L5	1.09e-05	5	194	3	IPR012561
Domain	Ferlin_C	DYSF OTOF FER1L5	1.09e-05	5	194	3	PF16165
Domain	Ferlin_C	DYSF OTOF FER1L5	1.09e-05	5	194	3	IPR032362
Domain	FerIin_dom	DYSF OTOF FER1L5	1.09e-05	5	194	3	IPR012968
Domain	FerI	DYSF OTOF FER1L5	1.09e-05	5	194	3	PF08151
Domain	FerB	DYSF OTOF FER1L5	1.09e-05	5	194	3	PF08150
Domain	Clathrin_H-chain_propeller_rpt	CLTCL1 CLTC	1.07e-04	2	194	2	IPR022365
Domain	Clathrin-link	CLTCL1 CLTC	1.07e-04	2	194	2	PF09268
Domain	-	CLTCL1 CLTC	1.07e-04	2	194	2	2.130.10.110
Domain	Clathrin_heavy_chain	CLTCL1 CLTC	1.07e-04	2	194	2	IPR016341
Domain	Clathrin_H-chain_propeller_N	CLTCL1 CLTC	1.07e-04	2	194	2	IPR001473
Domain	Clathrin_H-chain_link/propller	CLTCL1 CLTC	1.07e-04	2	194	2	IPR016025
Domain	Clathrin_propel	CLTCL1 CLTC	1.07e-04	2	194	2	PF01394
Domain	Clathrin_H-chain_linker_core	CLTCL1 CLTC	1.07e-04	2	194	2	IPR015348
Domain	FerA	DYSF FER1L5	3.20e-04	3	194	2	SM01200
Domain	Ferlin_A-domain	DYSF FER1L5	3.20e-04	3	194	2	IPR012560
Domain	Clathrin_H-chain_linker	CLTCL1 CLTC	3.20e-04	3	194	2	IPR012331
Domain	FerA	DYSF FER1L5	3.20e-04	3	194	2	PF08165
Domain	P-type_ATPase_IIA	ATP2A2 ATP2A3	3.20e-04	3	194	2	IPR005782
Domain	CLH	CLTCL1 CLTC	3.20e-04	3	194	2	SM00299
Domain	PROTEIN_KINASE_ATP	EPHB3 MATK LRRK2 PBK CDK14 NEK4 DCLK2 WNK3 MOS STK31 CSNK1D CSNK1E PRKACB PRKG1	3.27e-04	459	194	14	PS00107
Domain	Ser/Thr_kinase_AS	LRRK2 PBK CDK14 NEK4 DCLK2 WNK3 MOS STK31 CSNK1D CSNK1E PRKACB PRKG1	3.70e-04	357	194	12	IPR008271
Domain	PROTEIN_KINASE_ST	LRRK2 PBK CDK14 NEK4 DCLK2 WNK3 MOS STK31 CSNK1D CSNK1E PRKACB PRKG1	4.19e-04	362	194	12	PS00108
Domain	Kinase-like_dom	EPHB3 MATK LRRK2 PBK CDK14 NEK4 PTPN13 DCLK2 WNK3 MOS STK31 CSNK1D CSNK1E PRKACB PRKG1	5.58e-04	542	194	15	IPR011009
Domain	Prot_kinase_dom	EPHB3 MATK LRRK2 PBK CDK14 NEK4 DCLK2 WNK3 MOS STK31 CSNK1D CSNK1E PRKACB PRKG1	6.13e-04	489	194	14	IPR000719
Domain	TROPOMYOSIN	TPM1 TPM2	6.35e-04	4	194	2	PS00326
Domain	Tropomyosin	TPM1 TPM2	6.35e-04	4	194	2	IPR000533
Domain	-	ITGB3 ITGB6	6.35e-04	4	194	2	1.20.5.630
Domain	DysFC	DYSF FER1L5	6.35e-04	4	194	2	SM00694
Domain	DysFN	DYSF FER1L5	6.35e-04	4	194	2	SM00693
Domain	Tropomyosin	TPM1 TPM2	6.35e-04	4	194	2	PF00261
Domain	Peroxin/Ferlin	DYSF FER1L5	6.35e-04	4	194	2	IPR006614
Domain	Pkinase	LRRK2 PBK CDK14 NEK4 DCLK2 WNK3 MOS STK31 CSNK1D CSNK1E PRKACB PRKG1	6.58e-04	381	194	12	PF00069
Domain	PROTEIN_KINASE_DOM	EPHB3 MATK LRRK2 PBK CDK14 NEK4 DCLK2 WNK3 MOS STK31 CSNK1D CSNK1E PRKACB PRKG1	6.63e-04	493	194	14	PS50011
Domain	RII_binding_1	AKAP3 AKAP12	1.05e-03	5	194	2	PF10522
Domain	RII_binding_1	AKAP3 AKAP12	1.05e-03	5	194	2	IPR018459
Domain	S_TKc	LRRK2 PBK CDK14 NEK4 DCLK2 WNK3 MOS STK31 CSNK1D PRKACB PRKG1	1.37e-03	359	194	11	SM00220
Pathway	KEGG_DILATED_CARDIOMYOPATHY	TPM1 TPM2 ITGB3 ITGB6 CACNA1C CACNA2D4 PRKACB ATP2A2	3.36e-06	90	142	8	M835
Pathway	KEGG_HYPERTROPHIC_CARDIOMYOPATHY_HCM	TPM1 TPM2 ITGB3 ITGB6 CACNA1C CACNA2D4 ATP2A2	1.99e-05	83	142	7	M8728
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	TPM1 TPM2 GGNBP2 CLTCL1 ASH1L NCL ANKLE2 PGK2 TASOR2 CLTC CDNF SPDEF ALCAM AP3D1 LCMT1 CACNA1C PCDHGB3 SYNE1 HKDC1 CCT4 STK31 PRKACB ANKRD30A TMEM184C USPL1 ATP2A2 ATP2A3 CCDC158 MYBPC1	2.64e-09	1442	195	29	35575683
Pubmed	Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells.	TPM2 RRP1B TCEAL4 NCL RABGAP1 TOMM70 HIBCH MTUS1 GLG1 CLTC ALCAM DDX24 AMPD2 DSTN NAA15 ANXA6 ANXA11 QTRT2 RNF213 CCT4 HUWE1 NR3C1 AARSD1 AKAP12 USP14 EIF3J ATP2A2 EPB41	3.44e-09	1367	195	28	32687490
Pubmed	A High-Density Human Mitochondrial Proximity Interaction Network.	TPM1 RRP1B MYCBP2 NCL RABGAP1 ANKLE2 ITPR1 BLM TOMM70 HIBCH CLTC NAV1 DDX24 TDRKH NAA15 VEZT SYNE1 POLE RNF213 CCT4 HUWE1 POLR3A PIKFYVE GLMN CSNK1D CSNK1E MTR ATP2A2	2.38e-08	1496	195	28	32877691
Pubmed	SERBP1 Promotes Stress Granule Clearance by Regulating 26S Proteasome Activity and G3BP1 Ubiquitination and Protects Male Germ Cells from Thermostimuli Damage.	LDHAL6A ZFYVE16 NCL CDK14 TOMM70 CLTC USP15 LCMT1 DSTN NAA15 ANXA6 QTRT2 CCT4 HUWE1 NR3C1 ACSF2 AHSA1 AKAP12 USP14 ATP2A2 EPB41	2.79e-08	878	195	21	37223481
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	MAGI1 PDE2A MYCBP2 NCL EDC4 CLTC DIAPH2 NAV1 PLCL1 WNK3 NCOA2 GPM6A AMPD2 DSTN SYNE1 CCT4 NBEA HUWE1 AKAP12 PRKACB DZIP3 AGRN	2.87e-08	963	195	22	28671696
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	MAGI1 TRPM4 MYCBP2 ASH1L RABGAP1 WNT4 CDK14 TASOR2 PTPN13 NAV1 DCLK2 ALCAM USP15 NCOA2 CACNA1C VEZT RTF2 ANXA6 RNF213 HUWE1 USP14 CSNK1D PRKACB KYAT3 SPIDR SH3RF3 EPB41	8.24e-08	1489	195	27	28611215
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	FILIP1 KDM3A MYCBP2 MATK NCL BLM CLTC PACS2 PLCB3 DDX24 BAZ1B HUWE1 RFX7 TUBGCP6 CSNK1E PRPF38A ATP2A2 SNRNP200 CDH17	8.90e-08	774	195	19	15302935
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	TPM1 MAGI1 MYCBP2 MATK EDC4 CDK14 NEK4 PTPN13 MTUS1 NAV1 DCLK2 WNK3 AMPD2 NAA15 RFX7 CSNK1D CSNK1E EIF3J SH3RF3 EPB41	9.76e-08	861	195	20	36931259
Pubmed	Neuron-specific protein network mapping of autism risk genes identifies shared biological mechanisms and disease-relevant pathologies.	MYCBP2 NCL RABGAP1 EDC4 ANKLE2 ITPR1 GLG1 CLTC NAV1 DCLK2 USP15 CAP1 GPM6A AMPD2 NAA15 VEZT BSDC1 CCT4 NBEA HUWE1 CSNK1E ATP2A2 EPB41	1.26e-07	1139	195	23	36417873
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	RRP1B MYCBP2 NCL EDC4 TASOR2 BLM CLTC DDX24 CAP1 NAA15 POLE ANXA6 ANXA11 BAZ1B HUWE1 ATP2A2 SNRNP200	1.93e-07	653	195	17	22586326
Pubmed	A high-throughput approach for measuring temporal changes in the interactome.	TPM1 TPM2 TCEAL4 NCL RABGAP1 EDC4 PLCB3 USP15 AP3D1 CAP1 AMPD2 GNPDA1 NAA15 ANXA6 CCT4 API5 HUWE1 NR3C1 AHSA1 AARSD1 AKAP12 USP14 PRKACB MTR EIF3J SNRNP200	1.95e-07	1455	195	26	22863883
Pubmed	Defining the membrane proteome of NK cells.	KDM3A CLTCL1 MYCBP2 NCL EDC4 ANKLE2 APOBR ZDHHC3 ITPR1 TOMM70 GLG1 CLTC DDX24 AP3D1 PLSCR1 NAA15 ANXA6 ANXA11 RNF213 API5 HUWE1 POLR3A TUBGCP6	1.96e-07	1168	195	23	19946888
Pubmed	Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis.	CLTCL1 MYCBP2 ASH1L NCL EDC4 TOMM70 GLG1 CLTC PACS2 AP3D1 CAP1 DSTN SYNE1 CCT4 HUWE1 USP14 ATP2A2 SNRNP200	7.89e-07	807	195	18	30575818
Pubmed	FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia.	DYSF TGM5 BLM DIAPH2 DDX24 AP3D1 CACNA1C NBEA SNX14 XIRP2 ERCC6L2 KDM4A ATP2A3 SH3RF3	9.58e-07	497	195	14	36774506
Pubmed	A comprehensive SARS-CoV-2-human protein-protein interactome reveals COVID-19 pathobiology and potential host therapeutic targets.	TPM1 TPM2 PGK2 ITPR1 TOMM70 GLG1 ZMIZ2 CLTC MED23 AP3D1 CAP1 GPM6A AKAP12 ATP2A2	1.10e-06	503	195	14	36217030
Pubmed	Complementary proteomics strategies capture an ataxin-1 interactome in Neuro-2a cells.	NCL EDC4 PGK2 TOMM70 DDX24 DSTN MTERF1 HKDC1 CCT4 API5 HUWE1 AHSA1 AKAP12 PRKACB ATP2A2 SNRNP200	1.26e-06	665	195	16	30457570
Pubmed	Nuclear lamina genetic variants, including a truncated LAP2, in twins and siblings with nonalcoholic fatty liver disease.	TPM1 TPM2 NCL EDC4 CLTC CCT4 HUWE1 AHSA1 ATP2A2 SNRNP200	1.34e-06	244	195	10	28902428
Pubmed	Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis.	TPM1 TPM2 CLTCL1 RRP1B PBK NCL RABGAP1 PGK2 CLTC AP3D1 NAA15 ANXA6 ANXA11 HKDC1 CCT4 API5 POLR3A SNRNP200	1.57e-06	847	195	18	35235311
Pubmed	Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation.	RRP1B NCL EDC4 TOMM70 CLTC MED23 DDX24 CAP1 SYNE1 POLE ANXA6 BAZ1B CCT4 API5 HUWE1 AHSA1 POLR3A GLMN METTL13 CSNK1E MTR ATP2A2 SNRNP200 MYBPC1	1.69e-06	1425	195	24	30948266
Pubmed	Hypertonicity-responsive ubiquitin ligase RNF183 promotes Na, K-ATPase lysosomal degradation through ubiquitination of its β1 subunit.	CTNNAL1 ZFYVE16 CLTC USP15 AP3D1 VEZT BSDC1 CCT4 NBEA HUWE1 AKAP12 ATP2A2 EPB41	1.75e-06	449	195	13	31732153
Pubmed	KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.	TPM1 PDE2A NCL EDC4 TOMM70 PTPRA C12orf50 CLTC NAV1 PACS2 DCLK2 PLCL1 AP3D1 KNG1 CAP1 GPM6A DSTN MTERF1 SYNE1 CCT4 NBEA CSNK1D ATP2A2 SNRNP200	1.82e-06	1431	195	24	37142655
Pubmed	Agrin has a pathological role in the progression of oral cancer.	TPM2 RABGAP1 CLTC NAA15 SYNE1 SNX14 AGRN SNRNP200 MYBPC1	1.88e-06	197	195	9	29872149
Pubmed	Defining the proximal interaction networks of Arf GTPases reveals a mechanism for the regulation of PLD1 and PI4KB.	LRRK2 NCL TASOR2 BLM PTPN13 CLTC AP3D1 TDRKH BSDC1 RNF213 CCT4 NBEA HUWE1 AKAP12 CRB1 SNRNP200 EPB41	2.10e-06	777	195	17	35844135
Pubmed	Phenotypic and Interaction Profiling of the Human Phosphatases Identifies Diverse Mitotic Regulators.	CTNNAL1 RRP1B ZFYVE16 MYCBP2 ANKLE2 ITPR1 BLM TOMM70 PTPN13 PTPRA MTUS1 CLTC VEZT RNF213 CCT4 NBEA HUWE1 GLMN PRPF38A ATP2A2	2.11e-06	1049	195	20	27880917
Pubmed	Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.	MYCBP2 NCL BLM CLTC DDX24 AP3D1 CAP1 DSTN NAA15 POLE RTF2 BAZ1B CCT4 HUWE1 KIF20B AARSD1 POLR3A USP14 METTL13 PRPF38A ATP2A2 AGRN SNRNP200	2.42e-06	1353	195	23	29467282
Pubmed	Comprehensive interactome profiling of the human Hsp70 network highlights functional differentiation of J domains.	RRP1B MYCBP2 NCL ANKLE2 ITPR1 BLM PTPN13 GLG1 CLTC DDX24 AP3D1 NAA15 VEZT SYNE1 POLE BAZ1B NR3C1 AKAP12 TUBGCP6 CSNK1E PRKACB MTR ATP2A2 SNRNP200	3.50e-06	1487	195	24	33957083
Pubmed	Identifications of novel host cell factors that interact with the receptor-binding domain of the SARS-CoV-2 spike protein.	GGNBP2 NCL ITGB3 ITPR1 TOMM70 DIAPH2 PLCB3 AP3D1 NAA15 POLE NR3C1 CLSTN1 POLR3A MTR AGRN	4.51e-06	650	195	15	38777146
Pubmed	Destabilization of Atoh1 by E3 Ubiquitin Ligase Huwe1 and Casein Kinase 1 Is Essential for Normal Sensory Hair Cell Development.	MYCBP2 RNF213 HUWE1 AHSA1 CSNK1D CSNK1E	4.54e-06	76	195	6	27542412
Pubmed	A protein-interaction network of interferon-stimulated genes extends the innate immune system landscape.	TPM1 TPM2 CLTCL1 RRP1B EDC4 ITPR1 TOMM70 CLTC DDX24 AP3D1 DSTN ANXA6 QTRT2 RNF213 CCT4 HUWE1 POLR3A USP14 GLMN EIF3J ATP2A2 VPS53 SNRNP200	6.74e-06	1440	195	23	30833792
Pubmed	KAP1 facilitates reinstatement of heterochromatin after DNA replication.	CLTC DDX24 AP3D1 LCMT1 POLE RTF2 ANXA11 BAZ1B CCT4 HUWE1 POLR3A METTL13 PRPF38A ATP2A3 SNRNP200	1.16e-05	704	195	15	29955894
Pubmed	Construction of long-transcript enriched cDNA libraries from submicrogram amounts of total RNAs by a universal PCR amplification method.	TPM1 CTNNAL1 ASH1L ANKLE2 ITPR1 PTPN13 GLG1 CLTC P2RY14 NCOA2 AMPD2 CD300LF BAZ1B HUWE1 AKAP12 CSNK1E DZIP3 PRPF38A AGRN	1.26e-05	1084	195	19	11544199
Pubmed	SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.	KDM3A MYCBP2 EDC4 PTPN13 CLTC MED23 USP15 NCOA2 BAZ1B HUWE1 USP14 SNRNP200 EPB41	1.52e-05	549	195	13	38280479
Pubmed	An antibody-based proximity labeling map reveals mechanisms of SARS-CoV-2 inhibition of antiviral immunity.	ZFYVE16 MYCBP2 ZDHHC3 NEK4 NAV1 USP15 VEZT AKAP3 RNF213 HUWE1 PIKFYVE USP14 GLMN CSNK1E MTR	1.86e-05	733	195	15	34672954
Pubmed	An organelle-specific protein landscape identifies novel diseases and molecular mechanisms.	MAGI1 RRP1B MYCBP2 TCP11L1 ANKLE2 BLM NEK4 PTPN13 NAV1 NKTR DDX24 USP15 AMPD2 QTRT2 XRCC4 AKAP12 DZIP3 PRPF38A VPS53 SH3RF3 SNRNP200	1.86e-05	1321	195	21	27173435
Pubmed	Phosphorylation of LRRK2 by casein kinase 1α regulates trans-Golgi clustering via differential interaction with ARHGEF7.	LRRK2 CSNK1D CSNK1E	2.02e-05	10	195	3	25500533
Pubmed	Insights into the ubiquitin-proteasome system of human embryonic stem cells.	TPM1 NCL CLTC AP3D1 DSTN L1TD1 CCT4 DZIP3 EIF3J	2.31e-05	269	195	9	29511261
Pubmed	Blocking an N-terminal acetylation-dependent protein interaction inhibits an E3 ligase.	NCL CLTC USP15 CAP1 RNF213 CCT4 HUWE1 AHSA1 USP14 EIF3J SNRNP200 EPB41	2.58e-05	495	195	12	28581483
Pubmed	Tumor suppressor BAP1 nuclear import is governed by transportin-1.	TPM1 MYCBP2 TCP11L1 NCL CLTC AP3D1 CAP1 DSTN NAA15 CCT4 API5 HUWE1 NR3C1 XRCC4 AHSA1 AKAP12 EIF3J ATP2A2 SNRNP200	2.80e-05	1149	195	19	35446349
Pubmed	C5orf51 is a component of the MON1-CCZ1 complex and controls RAB7A localization and stability during mitophagy.	ZFYVE16 RABGAP1 ANKLE2 ITPR1 PTPN13 DIAPH2 TDRKH VEZT NBEA AKAP12 PIKFYVE SNX14	3.07e-05	504	195	12	34432599
Pubmed	Isolation and characterization of a cDNA that encodes mouse fibroblast tropomyosin isoform 2.	TPM1 TPM2	3.13e-05	2	195	2	3244365
Pubmed	Mutations in RNA Polymerase III genes and defective DNA sensing in adults with varicella-zoster virus CNS infection.	POLR3A POLR3E	3.13e-05	2	195	2	29728610
Pubmed	CK1δ and CK1ε are components of human 40S subunit precursors required for cytoplasmic 40S maturation.	CSNK1D CSNK1E	3.13e-05	2	195	2	24424021
Pubmed	Phospholipid scramblase 1 binds to the promoter region of the inositol 1,4,5-triphosphate receptor type 1 gene to enhance its expression.	ITPR1 PLSCR1	3.13e-05	2	195	2	16091359
Pubmed	Changes in end-to-end interactions of tropomyosin affect mouse cardiac muscle dynamics.	TPM1 TPM2	3.13e-05	2	195	2	16501024
Pubmed	Parkinson's disease kinase LRRK2 coordinates a cell-intrinsic itaconate-dependent defence pathway against intracellular Salmonella.	LRRK2 ACOD1	3.13e-05	2	195	2	37640963
Pubmed	Regulation of casein kinase I epsilon and casein kinase I delta by an in vivo futile phosphorylation cycle.	CSNK1D CSNK1E	3.13e-05	2	195	2	9632646
Pubmed	A novel point mutation in helix 11 of the ligand-binding domain of the human glucocorticoid receptor gene causing generalized glucocorticoid resistance.	NCOA2 NR3C1	3.13e-05	2	195	2	17635946
Pubmed	Identification of nucleolin as a glucocorticoid receptor interacting protein.	NCL NR3C1	3.13e-05	2	195	2	11162542
Pubmed	Rescue of tropomyosin-induced familial hypertrophic cardiomyopathy mice by transgenesis.	TPM1 TPM2	3.13e-05	2	195	2	17416600
Pubmed	Renaturation of skeletal muscle tropomyosin: implications for in vivo assembly.	TPM1 TPM2	3.13e-05	2	195	2	3857586
Pubmed	Modulation of B-cell endoplasmic reticulum calcium homeostasis by Epstein-Barr virus latent membrane protein-1.	ATP2A2 ATP2A3	3.13e-05	2	195	2	19650915
Pubmed	Insights into negative regulation by the glucocorticoid receptor from genome-wide profiling of inflammatory cistromes.	NCOA2 NR3C1	3.13e-05	2	195	2	23159735
Pubmed	Elevated tropomyosin expression is associated with epithelial-mesenchymal transition of lens epithelial cells.	TPM1 TPM2	3.13e-05	2	195	2	23205574
Pubmed	Multiple and diverse coexpression, location, and regulation of additional SERCA2 and SERCA3 isoforms in nonfailing and failing human heart.	ATP2A2 ATP2A3	3.13e-05	2	195	2	19962989
Pubmed	Nucleolin mediates the binding of cancer cells to L-selectin under conditions of lymphodynamic shear stress.	NCL SELL	3.13e-05	2	195	2	31644306
Pubmed	A novel point mutation in the ligand-binding domain (LBD) of the human glucocorticoid receptor (hGR) causing generalized glucocorticoid resistance: the importance of the C terminus of hGR LBD in conferring transactivational activity.	NCOA2 NR3C1	3.13e-05	2	195	2	15769988
Pubmed	FGF2 antagonizes aberrant TGFβ regulation of tropomyosin: role for posterior capsule opacity.	TPM1 TPM2	3.13e-05	2	195	2	27976512
Pubmed	Structural and functional properties of αβ-heterodimers of tropomyosin with myopathic mutations Q147P and K49del in the β-chain.	TPM1 TPM2	3.13e-05	2	195	2	30545627
Pubmed	Characterization of a second human clathrin heavy chain polypeptide gene (CLH-22) from chromosome 22q11.	CLTCL1 CLTC	3.13e-05	2	195	2	8733129
Pubmed	Receptor-binding domain of SARS-CoV-2 is a functional αv-integrin agonist.	ITGB3 ITGB6	3.13e-05	2	195	2	36669646
Pubmed	Casein kinase I delta/epsilon phosphorylates topoisomerase IIalpha at serine-1106 and modulates DNA cleavage activity.	CSNK1D CSNK1E	3.13e-05	2	195	2	19043076
Pubmed	Regulation of SERCA pumps expression in diabetes.	ATP2A2 ATP2A3	3.13e-05	2	195	2	25270119
Pubmed	Binding of the N-terminal region of coactivator TIF2 to the intrinsically disordered AF1 domain of the glucocorticoid receptor is accompanied by conformational reorganizations.	NCOA2 NR3C1	3.13e-05	2	195	2	23132854
Pubmed	CHC22 and CHC17 clathrins have distinct biochemical properties and display differential regulation and function.	CLTCL1 CLTC	3.13e-05	2	195	2	29097553
Pubmed	Anti-oncogenic effects of tropomyosin: isoform specificity and importance of protein coding sequences.	TPM1 TPM2	3.13e-05	2	195	2	8760295
Pubmed	Electrically-evoked responses for retinal prostheses are differentially altered depending on ganglion cell types in outer retinal neurodegeneration caused by Crb1 gene mutation.	PDE6B CRB1	3.13e-05	2	195	2	36814867
Pubmed	A fraction enriched in a novel glucocorticoid receptor-interacting protein stimulates receptor-dependent transcription in vitro.	NCL NR3C1	3.13e-05	2	195	2	8530516
Pubmed	Crystal structure of the glucocorticoid receptor ligand binding domain reveals a novel mode of receptor dimerization and coactivator recognition.	NCOA2 NR3C1	3.13e-05	2	195	2	12151000
Pubmed	The clathrin heavy chain isoform CHC22 functions in a novel endosomal sorting step.	CLTCL1 CLTC	3.13e-05	2	195	2	20065094
Pubmed	Effects of altered expression and activity levels of CK1δ and ɛ on tumor growth and survival of colorectal cancer patients.	CSNK1D CSNK1E	3.13e-05	2	195	2	25404202
Pubmed	Alterations in genes encoding sarcoplasmic-endoplasmic reticulum Ca(2+) pumps in association with head and neck squamous cell carcinoma.	ATP2A2 ATP2A3	3.13e-05	2	195	2	18295663
Pubmed	PLSCR1/IP3R1/Ca2+ axis contributes to differentiation of primary AML cells induced by wogonoside.	ITPR1 PLSCR1	3.13e-05	2	195	2	28492556
Pubmed	Developmental analysis of tropomyosin gene expression in embryonic stem cells and mouse embryos.	TPM1 TPM2	3.13e-05	2	195	2	7684495
Pubmed	Mechanisms of control of the free Ca2+ concentration in the endoplasmic reticulum of mouse pancreatic β-cells: interplay with cell metabolism and [Ca2+]c and role of SERCA2b and SERCA3.	ATP2A2 ATP2A3	3.13e-05	2	195	2	21885870
Pubmed	Abnormal vibrissa-related behavior and loss of barrel field inhibitory neurons in 5xFAD transgenics.	PDE6B DYSF	3.13e-05	2	195	2	24655396
Pubmed	Association of CACNA1C and SYNE1 in offspring of patients with psychiatric disorders.	CACNA1C SYNE1	3.13e-05	2	195	2	27620326
Pubmed	A novel mutation of the hGR gene causing Chrousos syndrome.	NCOA2 NR3C1	3.13e-05	2	195	2	26031419
Pubmed	Genotyping single point mutations in rd1 and rd8 mice using melting curve analysis of qPCR fragments.	PDE6B CRB1	3.13e-05	2	195	2	39198547
Pubmed	An evaluation of polymorphisms in casein kinase 1 delta and epsilon genes in major psychiatric disorders.	CSNK1D CSNK1E	3.13e-05	2	195	2	22981886
Pubmed	RNA binding proteins co-localize with small tau inclusions in tauopathy.	PDE2A NCL CLTC DCLK2 CAP1 GPM6A DSTN AHSA1 ATP2A2	3.43e-05	283	195	9	30068389
Pubmed	Molecular diversity of myofibrillar proteins: gene regulation and functional significance.	TPM1 TPM2 MYBPC1	3.68e-05	12	195	3	8618961
Pubmed	SR protein kinases promote splicing of nonconsensus introns.	RRP1B MYCBP2 ABCA13 NCL OTOF SPDEF RASGRF1 STK31 CARD11 PRPF38A	4.07e-05	361	195	10	26167880
Pubmed	Interaction proteomics analysis of polycomb proteins defines distinct PRC1 complexes in mammalian cells.	KDM3A MYCBP2 NCL RNF213 KIF20B CCDC158	5.12e-05	116	195	6	21282530
Pubmed	Identification of motif-based interactions between SARS-CoV-2 protein domains and human peptide ligands pinpoint antiviral targets.	NCOA2 CD300LF SYNE1 SLCO6A1 AKAP12 PIKFYVE XIRP2 MCM9	5.51e-05	233	195	8	37704626
Pubmed	USP45 and Spindly are part of the same complex implicated in cell migration.	CLTCL1 CLTC DIAPH2 WNK3 CCT4 CLSTN1 EIF3J SNRNP200	5.85e-05	235	195	8	30258100
Pubmed	Maternal Transient Receptor Potential Vanilloid 6 (Trpv6) Is Involved In Offspring Bone Development.	ITPR1 CACNA1C ATP2A2 ATP2A3	6.09e-05	38	195	4	30786075
Pubmed	Synthetic Lethal and Resistance Interactions with BET Bromodomain Inhibitors in Triple-Negative Breast Cancer.	TCEAL4 NCL RABGAP1 BLM MED23 DSTN POLE RTF2 BAZ1B RNF213 CCT4 API5 XRCC4 AHSA1 POLR3A USP14 EIF3J	6.35e-05	1014	195	17	32416067
Pubmed	Multipotent genetic suppression of retrotransposon-induced mutations by Nxf1 through fine-tuning of alternative splicing.	DYSF AP3D1 USP14	7.51e-05	15	195	3	19436707
Pubmed	∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis.	TPM1 TPM2 CLTCL1 LDHAL6A CLTC CAP1 DSTN CCT4 HUWE1 AHSA1 AKAP12 ATP2A2 ATP2A3	8.14e-05	647	195	13	26618866
Pubmed	Genetic and Proteomic Interrogation of Lower Confidence Candidate Genes Reveals Signaling Networks in β-Catenin-Active Cancers.	TPM1 MAGI1 RRP1B NCL CLTC DDX24 USP15 CAP1 DSTN CCT4 API5 HUWE1 RFX7 AHSA1 USP14 CSNK1D CSNK1E EIF3J ATP2A2	8.31e-05	1247	195	19	27684187
Pubmed	LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling.	EDC4 ANKLE2 TOMM70 CLTC WNK3 AMPD2 NAA15 VEZT POLE HUWE1 CLSTN1 USP14 GLMN MTR ATP2A2 VPS53	9.02e-05	942	195	16	31073040
Pubmed	C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains.	MYCBP2 TCEAL4 NCL TOMM70 CLTC USP15 DSTN POLE QTRT2 CCT4 HUWE1 AHSA1 POLR3A METTL13 CSNK1D CSNK1E MTR ATP2A2 SNRNP200	9.22e-05	1257	195	19	37317656
Pubmed	The role of gene polymorphisms in endometriosis.	WNT4 VEZT	9.35e-05	3	195	2	28901453
Pubmed	Functional equivalence of the clathrin heavy chains CHC17 and CHC22 in endocytosis and mitosis.	CLTCL1 CLTC	9.35e-05	3	195	2	19509056
Pubmed	Up-regulation of the fibroblast growth factor 8 subfamily in human hepatocellular carcinoma for cell survival and neoangiogenesis.	FGF18 FGF17	9.35e-05	3	195	2	21319186
Pubmed	Centrosomal anchoring of the protein kinase CK1delta mediated by attachment to the large, coiled-coil scaffolding protein CG-NAP/AKAP450.	CSNK1D CSNK1E	9.35e-05	3	195	2	12270714
Pubmed	Annexin A6 and Late Endosomal Cholesterol Modulate Integrin Recycling and Cell Migration.	ITGB3 ANXA6	9.35e-05	3	195	2	26578516
Pubmed	Modulation of endoplasmic reticulum calcium pump by Bcl-2.	ATP2A2 ATP2A3	9.35e-05	3	195	2	9788433
Pubmed	Survey of common eye diseases in laboratory mouse strains.	PDE6B CRB1	9.35e-05	3	195	2	23800770
Pubmed	Human platelet Ca2+-ATPases: new markers of cell differentiation as illustrated in idiopathic scoliosis.	ATP2A2 ATP2A3	9.35e-05	3	195	2	16973504
Interaction	RYR2 interactions	TPM1 TPM2 NCL ITPR1 CACNA1C NR3C1 PRKACB	1.36e-06	58	194	7	int:RYR2
Interaction	MYH2 interactions	TPM1 PDE2A USP15 NR3C1 AHSA1 PRKACB	1.16e-05	53	194	6	int:MYH2
GeneFamily	Ferlin family	DYSF OTOF FER1L5	5.76e-06	6	121	3	828
GeneFamily	Tropomyosins	TPM1 TPM2	2.64e-04	4	121	2	777
GeneFamily	Zinc fingers MYND-type\|A-kinase anchoring proteins	AKAP3 NBEA AKAP12	9.41e-04	29	121	3	396
GeneFamily	CD molecules\|Integrin beta subunits	ITGB3 ITGB6	1.55e-03	9	121	2	1159
GeneFamily	ATPases Ca2+ transporting	ATP2A2 ATP2A3	1.55e-03	9	121	2	1209
GeneFamily	Tudor domain containing	TDRKH STK31 KDM4A	1.92e-03	37	121	3	780
GeneFamily	CD molecules\|Toll like receptors	TLR6 TLR5	1.93e-03	10	121	2	948
GeneFamily	Doublecortin superfamily	DCDC1 DCLK2	1.93e-03	10	121	2	1369
GeneFamily	Annexins\|Endogenous ligands	ANXA6 ANXA11	3.30e-03	13	121	2	404
Coexpression	HAMAI_APOPTOSIS_VIA_TRAIL_UP	GGNBP2 CTNNAL1 MYCBP2 TCEAL4 PBK NCL TASOR2 ITPR1 BLM PTPN13 MTUS1 NKTR NAA15 L1TD1 BAZ1B XRCC4 KIF20B MTR EIF3J PUS7L	1.11e-07	656	195	20	M18979
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN	KDM3A ZFYVE16 MYCBP2 RABGAP1 ANKLE2 ITPR1 BLM NEK4 PTPN13 PTPRA ALCAM USP15 PLSCR1 NCOA2 BAZ1B NR3C1 XRCC4 KIF20B PIKFYVE PRKACB MTR SPIDR	4.69e-07	856	195	22	M4500
Coexpression	NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_3DY_DN	TPM2 KDM3A GGNBP2 RRP1B TASOR2 ITPR1 NKTR MED23 DDX24 USP15 SGTB EIF1AD POLR3E USPL1 SNRNP200	9.37e-07	432	195	15	M41149
Coexpression	GSE7460_WT_VS_FOXP3_HET_ACT_TCONV_DN	TTC39C PTPN13 ZMIZ2 DCLK2 PLSCR1 TDRKH CCT4 GLMN KYAT3 EIF3J	2.61e-06	199	195	10	M5710
Coexpression	GSE7509_UNSTIM_VS_FCGRIIB_STIM_MONOCYTE_DN	KDM3A ZFYVE16 EDC4 ITPR1 NAV1 DCLK2 AP3D1 NBEA CCDC141	4.49e-06	166	195	9	M6826
Coexpression	BUSSLINGER_GASTRIC_IMMUNE_CELLS	GGNBP2 MYCBP2 MATK TTC39C ASH1L GIMAP7 ANKLE2 APOBR ITPR1 PTPRA GLG1 DDX24 USP15 CAP1 SYNE1 ANXA6 BAZ1B RNF213 CCT4 HUWE1 NR3C1 RFX7 PIKFYVE PRKACB DZIP3 MTR CARD11 SNRNP200	6.13e-06	1492	195	28	M40023
Coexpression	NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_UP	RRP1B TLR6 HIBCH P2RY14 ALCAM USP15 CAP1 CCT4 API5 NR3C1 ACSF2 XRCC4 GLMN CSNK1D EDEM2 PRKACB DZIP3 MTR TMEM184C KYAT3 KDM4A EIF3J ATP2A2 SNRNP200	1.31e-05	1215	195	24	M41122
Coexpression	GSE360_T_GONDII_VS_B_MALAYI_LOW_DOSE_DC_DN	TPM1 CTNNAL1 FBXL5 ZMIZ2 P2RY14 CAP1 SYNE1 TLR5 PRKACB	1.93e-05	199	195	9	M5219
Coexpression	GSE11961_MEMORY_BCELL_DAY7_VS_GERMINAL_CENTER_BCELL_DAY40_UP	MYCBP2 GIMAP7 ACOD1 TOMM70 P2RY14 STK31 METTL13 EIF3J USPL1	2.01e-05	200	195	9	M9358
Coexpression	GSE360_T_GONDII_VS_B_MALAYI_HIGH_DOSE_DC_DN	TPM1 CTNNAL1 RRP1B FBXL5 ZMIZ2 P2RY14 SYNE1 TLR5 PRKACB	2.01e-05	200	195	9	M5216
Coexpression	SCHLOSSER_SERUM_RESPONSE_DN	ZFYVE16 MYCBP2 PTPN13 HIBCH DIAPH2 AP3D1 NCOA2 GPM6A DSTN AKAP12 PIKFYVE GLMN PRKACB KDM4A USPL1 ATP2A2 SNRNP200	2.28e-05	705	195	17	M1410
CoexpressionAtlas	kidney_P0_JuxtaGlom_Ren1_top-relative-expression-ranked_1000	TPM1 TPM2 FILIP1 LRRK2 ITGB3 ITGB6 ITPR1 CPQ MTUS1 P2RY14 PLCL1 ALCAM KNG1 CAP1 GPM6A CACNA1C DSTN RGS7BP SYNE1 ANXA6 NR3C1 CCDC141 AARSD1 AKAP12 PRKG1 ATP2A2 PRDM16 AGRN	1.27e-08	905	192	28	gudmap_kidney_P0_JuxtaGlom_Ren1_1000
CoexpressionAtlas	kidney_P0_JuxtaGlom_Ren1_k-means-cluster#3_top-relative-expression-ranked_1000	TPM2 FILIP1 ITGB3 P2RY14 CACNA1C DSTN RGS7BP ANXA6 AARSD1 AKAP12 PRDM16 AGRN	1.55e-05	293	192	12	gudmap_kidney_P0_JuxtaGlom_Ren1_k3_1000
CoexpressionAtlas	NK cells, NK.MCMV1.Sp, CD3-,NK1.1+, Spleen, avg-3	PDE2A RRP1B GIMAP7 CDK14 BLM P2RY14 HERC6 PLSCR1 SELL CD300LF POLE RNF213 SH2D1B	3.14e-05	367	192	13	GSM538309_500
CoexpressionAtlas	DevelopingKidney_e15.5_Peripheral blastema_emap-27731_k-means-cluster#5_top-relative-expression-ranked_500	LRRK2 KNG1 HUWE1 ERCC6L2	3.44e-05	21	192	4	gudmap_developingKidney_e15.5_Peripheral blastema_500_k5
CoexpressionAtlas	dev gonad_e11.5_F_GonadVasMes_Flk_k-means-cluster#1_top-relative-expression-ranked_1000	MAGI1 KDM3A WNT4 CDK14 RNF213 GLMN MTR KYAT3 SPIDR MYBPC1	3.88e-05	224	192	10	gudmap_dev gonad_e11.5_F_GonadVasMes_Flk_k1_1000
ToppCell	nucseq-Epithelial-Epithelial_Alveolar\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	MAGI1 FILIP1 LRRK2 ITGB6 PTPN13 MTUS1 ALCAM GPM6A SYNE1 CCDC141 PRKG1 PRDM16	6.59e-11	194	195	12	53f3e49e91b1096f3226010e2de767efb490dfe4
ToppCell	Tracheal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_airway_ASM\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	TPM1 TPM2 FILIP1 DYSF DCLK2 PLCL1 GPM6A CACNA1C COL4A6 DSTN SYNE1 PRKG1	8.35e-11	198	195	12	22e766df1276c5b14aa0d83f434f47140ebb98ea
ToppCell	Tracheal-NucSeq-Stromal-Myofibroblastic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	TPM1 TPM2 FILIP1 DYSF DCLK2 PLCL1 GPM6A CACNA1C COL4A6 SYNE1 PRKG1	1.31e-09	198	195	11	c12e7511628db819a52959bb68580e27c00c2e41
ToppCell	RV-06._Ventricular_Cardiomyocyte_II\|RV / Chamber and Cluster_Paper	TPM1 TPM2 MAGI1 FILIP1 PLCL1 CACNA1C CCDC141 PRKG1 ATP2A2 PRDM16	1.25e-08	190	195	10	fe8e78922c8ae928ef9a80bffd67868d5a87a091
ToppCell	nucseq-Epithelial\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	MAGI1 FILIP1 LRRK2 ITGB6 PTPN13 MTUS1 ALCAM GPM6A SYNE1 PRKG1	1.61e-08	195	195	10	9406866f99555198a9be311fbd65751b70f35446
ToppCell	Tracheal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_pulmonary\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	TPM1 TPM2 FILIP1 DCLK2 GPM6A CACNA1C COL4A6 SYNE1 AKAP12 PRKG1	1.77e-08	197	195	10	ac4f53acb2f8a428b0f2fab3c30a34e095a1bed7
ToppCell	Bronchial-NucSeq-Epithelial-Epi_alveolar\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	MAGI1 FILIP1 LRRK2 ITGB6 PTPN13 MTUS1 ALCAM RASGRF1 CCDC141 PRDM16	1.95e-08	199	195	10	725610310e5c5fd7120c0be9acb55bf152026ddd
ToppCell	PND28-Endothelial-Endothelial_lymphatic\|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CTNNAL1 CPQ CDNF GPM6A RGS7BP BSDC1 ACSF2 AARSD1 SPIDR	7.53e-08	173	195	9	2978c744d3c8dcaa2b9bb225abf846f82e8f9176
ToppCell	PND28-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC-LEC_mature\|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CTNNAL1 CPQ CDNF GPM6A RGS7BP BSDC1 ACSF2 AARSD1 SPIDR	7.53e-08	173	195	9	23d4a315a0ad5c6fc77bcfc18b6c1ff55be99e8f
ToppCell	PND28-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC\|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CTNNAL1 CPQ CDNF GPM6A RGS7BP BSDC1 ACSF2 AARSD1 SPIDR	7.53e-08	173	195	9	03b50b2376d353748a32bf14a9fc8341ea61dbca
ToppCell	PND28-Endothelial-Endothelial_lymphatic-Lymphatic_EC\|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CTNNAL1 CPQ CDNF GPM6A RGS7BP BSDC1 ACSF2 AARSD1 SPIDR	7.53e-08	173	195	9	12da47b90aecedaa31764ff7ddb853ee39123e9d
ToppCell	human_hepatoblastoma-Hepatic_Stellate_cells\|World / Sample and Cell Type and Tumor Cluster (all cells)	FILIP1 CDK14 ITPR1 PTPN13 DCLK2 PLCL1 CACNA1C RGS7BP PRKG1	1.40e-07	186	195	9	cb1fc4b9140666b43415e21c9b434dc9b144e9d0
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2-D062\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	MAGI1 LRRK2 ZDHHC3 ITGB6 PTPN13 MTUS1 ALCAM RASGRF1 CCDC141	1.46e-07	187	195	9	5df9e1f5ca32217af255e76e6fb5afa346337811
ToppCell	Control-Epithelial_cells\|Control / group, cell type (main and fine annotations)	MAGI1 LRRK2 ITGB6 PTPN13 MTUS1 ALCAM GPM6A DSTN CCDC141	1.53e-07	188	195	9	707ebf76cc6fb600b2f07793cf4ea9482c0de79d
ToppCell	Children_(3_yrs)-Epithelial\|Children_(3_yrs) / Lineage, Cell type, age group and donor	MAGI1 FILIP1 LRRK2 ITGB6 PTPN13 MTUS1 GPM6A CCDC141 PRDM16	1.75e-07	191	195	9	e432c6e1ae82dddf84314ce73d2b7a991630d905
ToppCell	Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)\|World / Lineage, Cell type, age group and donor	MAGI1 FILIP1 LRRK2 ITGB6 PTPN13 MTUS1 ALCAM GPM6A PRDM16	1.75e-07	191	195	9	d3733c8c4bda70c4390e5601fdda6188a64be944
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D062\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	MAGI1 LRRK2 ITGB6 MTUS1 PLCL1 ALCAM GPM6A CCDC141 PRDM16	1.83e-07	192	195	9	29f49f00770c991b5f27e4cb701dd2d2d6cb7178
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	MAGI1 LRRK2 ITGB6 PTPN13 MTUS1 ALCAM RGS7BP RASGRF1 CCDC141	1.83e-07	192	195	9	fb2f0e897228f808d9ff734ad05e9b49dc38fa50
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FILIP1 MYCBP2 ASH1L CLTC NKTR NBEA HUWE1 ATP2A2 ATP2A3	2.09e-07	195	195	9	7796ea9247f4c63762f0de8490fed08b9717fa23
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FILIP1 MYCBP2 ASH1L CLTC NKTR NBEA HUWE1 ATP2A2 ATP2A3	2.09e-07	195	195	9	3e519cffa6144a62b06124642a14c9ff39b76554
ToppCell	COVID-19_Moderate\|World / disease group, cell group and cell class	ASH1L OTOF NKTR HERC6 DDX24 SELL SYNE1 RNF213 EPB41	2.48e-07	199	195	9	952fac67588ad5676f5939e3c7f8bac803c27064
ToppCell	RV-13._Vascular_Smooth_Muscle\|RV / Chamber and Cluster_Paper	TPM1 TPM2 CACNA1C DSTN RGS7BP AKAP12 RANBP3L PRKG1	5.74e-07	161	195	8	47b3b7662cbb671ccc086dc0a0cabd65f63eb5a1
ToppCell	saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c03-GZMK\|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k)	RRP1B GIMAP7 HIBCH ANXA6 KIF20B GLMN ERCC6L2 CARD11	5.74e-07	161	195	8	d72c572613f8eff3251cb7b1e9dcc76d193b2f21
ToppCell	droplet-Heart-4Chambers-21m-Mesenchymal-nan\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KDM3A TLR6 BLM P2RY14 PLCL1 RASGRF1 CLSTN1 SH3RF3	1.28e-06	179	195	8	b44e2d53b82c3c141bfc6539054b19708200a0d9
ToppCell	normal_Pleural_Fluid-Myeloid_cells-CD1c+_DCs\|Myeloid_cells / Location, Cell class and cell subclass	TRPM4 CACNA1C CCDC141 AKAP12 CARD11 PRDM16 ATP2A3 CDH17	1.39e-06	181	195	8	cc7ae1221a28bc404138a7efee0ad08a19cc3d86
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	MAGI1 FILIP1 LRRK2 ITGB6 PTPN13 MTUS1 RASGRF1 CCDC141	1.51e-06	183	195	8	6847c1252d6bb105524f812658112517fd351eab
ToppCell	COPD-Epithelial-ATII\|World / Disease state, Lineage and Cell class	MAGI1 LRRK2 ITGB6 PTPN13 MTUS1 SYNE1 CCDC141 PRKG1	1.51e-06	183	195	8	8e9aab4eeec2e282c2cab9bfca6dbf40d660c7b9
ToppCell	LV-15._Ventricular_Cardiomyocyte_III\|LV / Chamber and Cluster_Paper	TPM1 TPM2 MAGI1 FILIP1 PLCL1 CACNA1C CCDC141 XIRP2	1.57e-06	184	195	8	ab7a1620c14a9d9b6be1b47c559931e345e9eef8
ToppCell	Control-Stromal-SMC\|World / Disease state, Lineage and Cell class	TPM1 TPM2 CACNA1C DSTN AKAP12 INMT PRKG1 PRDM16	1.57e-06	184	195	8	88b1a4c9a96a99fc3a39f7a2c3d0838739606f3e
ToppCell	LV-15._Ventricular_Cardiomyocyte_III\|World / Chamber and Cluster_Paper	TPM1 TPM2 MAGI1 FILIP1 PLCL1 CACNA1C CCDC141 XIRP2	1.64e-06	185	195	8	6baccb26f999145e51b91d94315bf8d4655bef31
ToppCell	CV-Moderate-7\|CV / Virus stimulation, Condition and Cluster	MYCBP2 ASH1L CLTC ALCAM RNF213 HUWE1 MCM9 USPL1	1.70e-06	186	195	8	8571956890fc9894d766ba294a28e376b4aba428
ToppCell	Control-Epithelial-ATII\|World / Disease state, Lineage and Cell class	MAGI1 ITGB6 PTPN13 MTUS1 RASGRF1 HKDC1 CCDC141 PRKG1	1.70e-06	186	195	8	f4b6e401e19a71beddc73d8a1e08359f7c4025cf
ToppCell	IPF-Epithelial-ATII\|World / Disease state, Lineage and Cell class	MAGI1 LRRK2 ITGB6 PTPN13 MTUS1 RASGRF1 CCDC141 PRKG1	1.70e-06	186	195	8	6a4ff2da0af0f5e590d9f9daa5b5e9ac8c868947
ToppCell	nucseq-Mesenchymal-Myocytic-Myocytic_2-VSMC\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	TPM1 TPM2 TCEAL4 CACNA1C DSTN AKAP12 INMT PRKG1	1.70e-06	186	195	8	c7885fd6dc7dc8fffc96f0112c51a365cf8a8f80
ToppCell	Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte\|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	LRRK2 APOBR DIAPH2 NAV1 USP15 COL4A6 PRDM16 PIWIL3	1.70e-06	186	195	8	23b8d51d20b05795a73892d3e20e0f9b6a207820
ToppCell	LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT2\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FILIP1 LRRK2 ITGB6 PTPN13 MTUS1 COL4A6 CCDC39 PRDM16	1.70e-06	186	195	8	e83718fabb057100835d3357df407f283d23fe16
ToppCell	LA-03._Atrial_Cardiomyocyte\|World / Chamber and Cluster_Paper	TPM1 TPM2 MAGI1 FILIP1 CLTCL1 DYSF CACNA1C ATP2A2	1.84e-06	188	195	8	6d249fe92d51a19da19ec14bb2262d394255d577
ToppCell	LA-13._Vascular_Smooth_Muscle\|LA / Chamber and Cluster_Paper	TPM1 TPM2 ITPR1 CACNA1C DSTN RGS7BP PRKG1 PRDM16	1.84e-06	188	195	8	34e1b074a3995aa46ab194eb45115d76d1a5514d
ToppCell	COVID-19_Mild-Treg\|COVID-19_Mild / Disease condition and Cell class	TTC39C CDK14 PLCL1 USP15 SELL SGTB CCDC141 EPB41	1.92e-06	189	195	8	f0fceb5f87ca260bfe038c0db3487a6d2e1b0a6e
ToppCell	RV-06._Ventricular_Cardiomyocyte_II\|World / Chamber and Cluster_Paper	MAGI1 FILIP1 PLCL1 CACNA1C CCDC141 XIRP2 ATP2A2 PRDM16	1.92e-06	189	195	8	5e80c47f63980904c4c1ff02c201b67b456a0974
ToppCell	droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal-smooth_muscle_cell\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TPM1 TPM2 FILIP1 MTUS1 PLCL1 CACNA1C CCDC141 PRKG1	2.00e-06	190	195	8	1ab3f19f1ce9f58e5125135704d94655a2e330a0
ToppCell	LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	TPM1 FGF18 ITPR1 P2RY14 PLCL1 CACNA1C SYNE1 PRKG1	2.08e-06	191	195	8	7853ac7dff649150e6ff27cd4c8cf7c1fc034ed4
ToppCell	LV-06._Ventricular_Cardiomyocyte_II\|LV / Chamber and Cluster_Paper	TPM2 MAGI1 FILIP1 PLCL1 CACNA1C CCDC141 PRKG1 ATP2A2	2.08e-06	191	195	8	25f3eb34f4e70761e81e84c8a5829f216108cbc6
ToppCell	CD8+_Memory_T_cell-CV-7\|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster	MYCBP2 GLG1 NKTR ALCAM RNF213 HUWE1 MCM9 USPL1	2.08e-06	191	195	8	9454f642c3621370fa23640b631301346b300950
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	MAGI1 LRRK2 ITGB6 MTUS1 ALCAM GPM6A CCDC141 PRDM16	2.08e-06	191	195	8	ca5669bd6f4a17471acae3eb229f845cc2e08efa
ToppCell	Control-Multiplet-Multiplet\|World / Disease state, Lineage and Cell class	MAGI1 ITGB6 PTPN13 MTUS1 SYNE1 HKDC1 CCDC141 PRKG1	2.16e-06	192	195	8	1bfd022d5b87cf8a5d5069f559339a553a52a0a2
ToppCell	Epithelial\|World / Lineage, Cell type, age group and donor	MAGI1 LRRK2 ITGB6 PTPN13 MTUS1 ALCAM GPM6A PRDM16	2.16e-06	192	195	8	499e8893afea5e6d3371e0bd018f7e86a524d669
ToppCell	Adult-Epithelial-alveolar_epithelial_cell_type_2-D122\|Adult / Lineage, Cell type, age group and donor	MAGI1 LRRK2 ITGB6 PTPN13 MTUS1 RASGRF1 CCDC141 PRKG1	2.16e-06	192	195	8	06013a07e3a873b1d1c0451643c528593ac32a9c
ToppCell	Adult-Epithelial\|Adult / Lineage, Cell type, age group and donor	MAGI1 FILIP1 LRRK2 ITGB6 PTPN13 MTUS1 PRKG1 PRDM16	2.16e-06	192	195	8	efb962a5fd3b9bdfd8cf8d13c435e29c8271713e
ToppCell	5'-GW_trimst-2-LargeIntestine-Mesenchymal-myocytic-SMC_(PART1/CAPN3+)\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	TPM1 TPM2 FILIP1 ALCAM GPM6A DSTN ANXA6 AKAP12	2.24e-06	193	195	8	0256e8fe4a47f2e2a43ef9d19bfc047d20806d69
ToppCell	CF-Lymphoid\|CF / Disease state, Lineage and Cell class	MYCBP2 TTC39C NCL TASOR2 RFX7 GLMN MTR CARD11	2.24e-06	193	195	8	11de07d13a7da223990b56fa89ba7fc1c3dd0122
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	MAGI1 DCDC1 ABCA13 LRRK2 ITGB6 SYNE1 ANXA11 RNF213	2.33e-06	194	195	8	e577d9e88390b36b5a09b97fe1026089892275a3
ToppCell	droplet-Limb_Muscle-MUSCLE-1m-Mesenchymal-smooth_muscle_cell\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TPM1 TPM2 FILIP1 MTUS1 PLCL1 CACNA1C RGS7BP PRKG1	2.33e-06	194	195	8	b8a130ffae68ffe550bf335460a1ec1035cf8d8d
ToppCell	3'-GW_trimst-1-SmallIntestine-Mesenchymal-myocytic-SMC_(PART1/CAPN3+)\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	TPM1 TPM2 FILIP1 ALCAM DSTN ANXA6 AKAP12 INMT	2.42e-06	195	195	8	bd7526dd80a60ff7bc866e4f5a0e8acdbc10d191
ToppCell	COVID-19-Heart-CM_2\|Heart / Disease (COVID-19 only), tissue and cell type	TPM1 MAGI1 FILIP1 PLCL1 CACNA1C CCDC141 XIRP2 ATP2A2	2.42e-06	195	195	8	75fc81bddb246dca3b437fb60827b1d4fe416405
ToppCell	3'-Parenchyma_lung-Epithelial\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	LRRK2 ITGB6 PTPN13 MTUS1 DSTN RASGRF1 SYNE1 CCDC141	2.42e-06	195	195	8	eec187c087e432417bc346c5d3ead72f58bf3215
ToppCell	saliva-Mild-Moderate_progression_d12-25-Lymphocytic\|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)	NCL ANXA6 RFX7 KIF20B PIKFYVE GLMN POLR3E CARD11	2.52e-06	196	195	8	fd756b247b2d8a291e8e71bec6f1e463d6557536
ToppCell	severe-low-quality_cells\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	NKTR MED23 DDX24 SYNE1 RNF213 AKAP12 SNRNP200 EPB41	2.61e-06	197	195	8	57ebd552f10d6278623b52a3d484d4b91ae1d028
ToppCell	T_cells-Treg_cells\|T_cells / Immune cells in Kidney/Urine in Lupus Nephritis	TCEAL4 CDK14 PLCL1 SELL CCDC141 TLR5 SH3RF3 EPB41	2.61e-06	197	195	8	ec9398ae3577f61d6b1e6aba50ef4261aaaa7610
ToppCell	mild-Treg\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	TTC39C PLCL1 DDX24 USP15 SGTB CCDC141 KIF20B EPB41	2.61e-06	197	195	8	39800e6e83f2d333b753d121c7aeb2912b91faa2
ToppCell	Control_saline-Epithelial_alveolar-AT_2-Differentiating_AT2\|Control_saline / Treatment groups by lineage, cell group, cell type	EPHB3 FILIP1 LRRK2 PTPN13 MTUS1 COL4A6 CCDC141 CCDC39	2.61e-06	197	195	8	44a59dfb889577b3160a5b13ada1276771a00241
ToppCell	Bronchial-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_pulmonary\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	TPM1 TPM2 DCLK2 CACNA1C RGS7BP AKAP12 PRKG1 SH3RF3	2.61e-06	197	195	8	bf0520a94ebb1d2f94de9f526d17e0b0e8fe7052
ToppCell	systemic_lupus_erythematosus-flare-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	MATK GIMAP7 SYNE1 ANXA6 RNF213 PRKACB DZIP3 EPB41	2.61e-06	197	195	8	4c9919914079e76b1d2220b249e0d0b0d9bf4bc0
ToppCell	AT2_cells-IPF_04\|World / lung cells shred on cell class, cell subclass, sample id	FILIP1 LRRK2 ITGB6 PTPN13 MTUS1 RASGRF1 SYNE1 BAZ1B	2.61e-06	197	195	8	fd7bdfa6bf5966ebc11fdd13915769429540ddbf
ToppCell	10x5'v1-week_12-13-Myeloid_neutrophil-granulo-neutrophil-neutrophil\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	TRPM4 LRRK2 DYSF APOBR SELL CD300LF SYNE1 ABTB1	2.61e-06	197	195	8	8dd10962b6ba587512b2e68c762ade68c751cbc8
ToppCell	control-Epithelial-Ciliated\|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	FILIP1 DCDC1 CCDC81 DIAPH2 SYNE1 ODAD2 CCDC39 DZIP3	2.61e-06	197	195	8	e453d085182364ca347cbcc9dc995c62c3353016
ToppCell	COVID-19_Mild\|World / Disease group, lineage and cell class	OTOF NKTR DDX24 USP15 PLSCR1 RNF213 CSNK1D CD300E	2.61e-06	197	195	8	5c33454b10023decd2f5ccda9229b6512659711e
ToppCell	control-Epithelial-Ciliated\|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	FILIP1 DCDC1 CCDC81 DIAPH2 SYNE1 ODAD2 CCDC39 DZIP3	2.61e-06	197	195	8	d4e963c1f82996371bf3d63578ee9fce8e00c5a8
ToppCell	systemic_lupus_erythematosus-flare\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	ASH1L NCL GIMAP7 NKTR SELL SYNE1 ANXA6 RNF213	2.71e-06	198	195	8	4c93ee921d56132d80832d8e94563f32ccf13bbc
ToppCell	tumor_Lung-Fibroblasts-Smooth_muscle_cells\|Fibroblasts / Location, Cell class and cell subclass	TPM1 TPM2 PDE2A RABGAP1 FGF18 ALCAM DSTN PRDM16	2.71e-06	198	195	8	f540f464118edc0fb809ebcb813d0302e6952253
ToppCell	Severe_COVID-19\|World / Disease group,lineage and cell class （2021.01.30）	GIMAP7 DYSF OTOF PLSCR1 SELL ANXA6 RNF213 CD300E	2.71e-06	198	195	8	09fd456077bb3a657ad3b10c6cfe799b7266456a
ToppCell	BAL-Severe\|BAL / Location, Disease Group, Cell group, Cell class (2021.03.09)	GIMAP7 DYSF OTOF PLSCR1 SELL ANXA6 RNF213 CD300E	2.71e-06	198	195	8	687f69c16343227854c882b4a0f3930ce534a3d2
ToppCell	PBMC-Mild\|PBMC / Location, Disease Group, Cell group, Cell class (2021.03.09)	OTOF NKTR HERC6 DDX24 USP15 PLSCR1 RNF213 CD300E	2.71e-06	198	195	8	44417089b62056269cac38d3134ff209c05b7007
ToppCell	PBMC-Mild\|PBMC / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	OTOF NKTR HERC6 DDX24 USP15 PLSCR1 RNF213 CD300E	2.71e-06	198	195	8	28ef3fc4c17dcb765537b75917f7db78baa522db
ToppCell	BAL-Severe\|BAL / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	GIMAP7 DYSF OTOF PLSCR1 SELL ANXA6 RNF213 CD300E	2.71e-06	198	195	8	454aee3f4fe6d0beeccc55200b4495f4f9b44feb
ToppCell	mild-low-quality_cells\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	ASH1L NKTR DDX24 USP15 SYNE1 RNF213 SNRNP200 EPB41	2.82e-06	199	195	8	f0b0097df0026496470a80d8cc9375ffd8389b00
ToppCell	Parenchymal-NucSeq-Epithelial-Epi_alveolar\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	MAGI1 ITGB6 PTPN13 MTUS1 ALCAM GPM6A CCDC141 PRDM16	2.82e-06	199	195	8	8587bd98de7767a575088afbea07a1feb4516b9b
ToppCell	healthy_donor-Lymphocytic\|healthy_donor / Disease condition, Lineage, Cell class and subclass	MATK SYNE1 ANXA6 RNF213 PRKACB CARD11 ATP2A3 EPB41	2.82e-06	199	195	8	2841e16d54acd344ba454f024e285c28abc37319
ToppCell	mild\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	MYCBP2 ASH1L NCL NKTR DDX24 USP15 RNF213 EPB41	2.92e-06	200	195	8	12f1685ce8f218433068e090c9d839cd5a1910bf
ToppCell	Bronchial-NucSeq-Stromal-Myofibroblastic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	TPM1 TPM2 DCLK2 CACNA1C COL4A6 AKAP12 PRKG1 SH3RF3	2.92e-06	200	195	8	a66449b22b39dd6987fc2c3ed160d24564234ced
ToppCell	mild-gd_T\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	MATK NCL NKTR DDX24 SYNE1 RNF213 PRKACB EPB41	2.92e-06	200	195	8	109f673a4967ffa52270a0b4f818b3461288db44
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-6m-Mesenchymal-Mesoderm\|6m / Sample Type, Dataset, Time_group, and Cell type.	TPM1 TPM2 FILIP1 DYSF ITGB6 CCDC141 XIRP2 MYBPC1	2.92e-06	200	195	8	0f6851baf0cf2a8b0c95a7a585c4407c330c5f6c
ToppCell	LPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	TPM1 MTUS1 DIAPH2 ALCAM DSTN SYNE1 ANXA6 PRKG1	2.92e-06	200	195	8	dcdaec3ca3a3024dc1b8788c417003f84c2bffdc
ToppCell	Control-Epithelial_alveolar-AT_1-AT2_Progenitor\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FILIP1 WNT4 ITGB6 COL4A6 CCDC39 XIRP2 PRDM16	3.13e-06	142	195	7	94e277f038f4006d99ff50222b0f5cf89bc3d46d
ToppCell	RV-13._Vascular_Smooth_Muscle\|World / Chamber and Cluster_Paper	TPM1 TPM2 CACNA1C DSTN RGS7BP RANBP3L PRKG1	6.87e-06	160	195	7	29c9b4770d0e73d59cffc7937b179484c76b6dcc
ToppCell	356C-Epithelial_cells-Epithelial-C_(AT2)-\|356C / Donor, Lineage, Cell class and subclass (all cells)	FILIP1 LRRK2 ITGB6 PTPN13 SPDEF RASGRF1 HKDC1	7.16e-06	161	195	7	78cb72c462167021195917a06052bcdc367ad890
ToppCell	356C-Epithelial_cells-Epithelial-C_(AT2)\|356C / Donor, Lineage, Cell class and subclass (all cells)	FILIP1 LRRK2 ITGB6 PTPN13 SPDEF RASGRF1 HKDC1	7.16e-06	161	195	7	06e7becfd11d6ef1a45a9cfdfcb40b812600038e
ToppCell	3'-GW_trimst-1.5-SmallIntestine-Mesenchymal-myocytic-SMC_(PART1/CAPN3+)\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	TPM1 TPM2 FILIP1 ALCAM DSTN AKAP12 INMT	7.76e-06	163	195	7	e526104a3a574ee860078ce7c049e7fec9443f37
ToppCell	droplet-Spleen-nan-24m-Myeloid-granulocyte\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ABCA13 ACOD1 MTUS1 DSTN CD300LF SYNE1 ABTB1	8.41e-06	165	195	7	3cdb921f5b9facf04f81995d5641ac14ef3dbb6f
ToppCell	PND03-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2-AT2_prolif\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CTNNAL1 LRRK2 CLTC GPM6A RASGRF1 HKDC1 KIF20B	9.46e-06	168	195	7	08f6e171a1ea5cf65149744296d0fcd6c7b9684e
ToppCell	facs-Marrow-Granulocytes-3m-Myeloid-granulocyte\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ABCA13 LRRK2 APOBR MTUS1 DSTN CD300LF SYNE1	1.06e-05	171	195	7	ab21f20ec041cbaacccbd7da4dccdb77ec8bc5c6
ToppCell	facs-Marrow-Granulocytes-3m-Myeloid-granulocyte\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ABCA13 LRRK2 APOBR MTUS1 DSTN CD300LF SYNE1	1.06e-05	171	195	7	97ad2cfff568a9d006ab1d2e6e00946ee4e3beb3
ToppCell	droplet-Marrow-BM-1m-Myeloid-granulocyte\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LRRK2 DSTN CD300LF SYNE1 ANXA11 BSDC1 ABTB1	1.06e-05	171	195	7	8a0c08f0aa3a80cd6346c81deb242e430ebd897b
ToppCell	facs-Marrow-Granulocytes\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ABCA13 APOBR MTUS1 DSTN CD300LF SYNE1 ABTB1	1.06e-05	171	195	7	1701dedf0c18751db6c9fee3d93fff150ed0e17f
ToppCell	3'-GW_trimst-1.5-LargeIntestine-Mesenchymal-myocytic-SMC_(PART1/CAPN3+)\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	TPM1 TPM2 FILIP1 ALCAM GPM6A DSTN AKAP12	1.06e-05	171	195	7	fe0665c5ca01b0b2cc8f20d64587f0847c3d215c
ToppCell	mild_COVID-19-Treg\|mild_COVID-19 / disease group, cell group and cell class (v2)	TTC39C PLCL1 SELL SGTB HKDC1 CCDC141 EPB41	1.10e-05	172	195	7	77af6324c06b67867e7ce07706536fe38de5ed7b
ToppCell	facs-Marrow-T_cells-18m-Myeloid-granulocyte\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	WNT4 APOBR MTUS1 DSTN CD300LF SYNE1 ABTB1	1.14e-05	173	195	7	0f9784b30c81a4a4940e0623cec60d596e9985d2
ToppCell	facs-Marrow-T_cells-18m-Myeloid-granulocyte\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	WNT4 APOBR MTUS1 DSTN CD300LF SYNE1 ABTB1	1.14e-05	173	195	7	60f79e0698a7cf7516690fb20f1b82ee46547699
ToppCell	nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-ASMC\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	TPM1 TPM2 DCLK2 PLCL1 CACNA1C PRKG1 PRDM16	1.14e-05	173	195	7	cb6389536195443633adb06e5f1b7483530773d1
ToppCell	droplet-Marrow-nan-18m-Hematologic-proerythroblast\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FBXL5 ACOD1 MTUS1 SELL CD300LF ANXA11 ABTB1	1.14e-05	173	195	7	03cee3d24bc433e91a867ce951589de64a0538af
Drug	PtdIns(4)P	CLTCL1 DYSF CLTC PLCB3 DSTN PIKFYVE CSNK1D CSNK1E	3.20e-06	104	195	8	CID000643965
Drug	mercury	LDHAL6A CDK14 ITPR1 CPQ CLTC PACS2 MED23 CACNA1C CCT4 NR3C1 PIKFYVE CACNA2D4 CARD11 USPL1 ATP2A2 ATP2A3 AGRN	4.64e-06	542	195	17	CID000023931
Drug	milrinone	PDE2A PDE6B PLCB3 SYNE1 PRKACB CARD11 PRKG1 ATP2A2 ATP2A3	6.05e-06	150	195	9	CID000004197
Drug	C11998	NCL NCOA2 CCT4 NR3C1	6.61e-06	15	195	4	CID005282036
Drug	Glutethimide, para-amino [125-84-8]; Down 200; 17.2uM; MCF7; HT_HG-U133A	EPHB3 DIAPH2 PLCB3 ANXA11 BAZ1B PRKACB KDM4A ATP2A2 ATP2A3 PUS7L	8.87e-06	199	195	10	7421_DN
Drug	arabinosyladenine	PDE2A CLTCL1 LDHAL6A PDE6B ITPR1 P2RY14 MED23 GPM6A CACNA1C AMPD2 ACTRT2 PIKFYVE CACNA2D4 POLR3E PRKACB CARD11 PRKG1 ATP2A2 ATP2A3 MYBPC1	9.43e-06	762	195	20	CID000000191
Drug	lavendustin A	MATK ITPR1 CACNA1C RASGRF1 CCT4 PIKFYVE CACNA2D4 PRKACB PRKG1	1.74e-05	171	195	9	CID000003894
Drug	5-IAF	TPM1 TPM2 PGK2 ACTRT2 PRKG1 EPB41	2.17e-05	66	195	6	CID000123822
Drug	17-AAG; Up 200; 1uM; HL60; HT_HG-U133A	TPM1 HIBCH MTUS1 MED23 HERC6 PLSCR1 ANXA6 AHSA1 PRKACB	2.19e-05	176	195	9	2666_UP
Disease	limb-girdle muscular dystrophy (implicated_via_orthology)	DYSF OTOF FER1L5	9.46e-06	7	193	3	DOID:11724 (implicated_via_orthology)
Disease	Distal arthrogryposis syndrome	TPM2 MYBPC1	4.26e-05	2	193	2	C0265213
Disease	Digitotalar dysmorphism; ulnar drift, hereditary	TPM2 MYBPC1	4.26e-05	2	193	2	cv:C1852085
Disease	Bipolar Disorder	MAGI1 ABCA13 FGF17 ITPR1 NEK4 CACNA1C RASGRF1 SYNE1 NR3C1 CSNK1E MTR CDH17	7.82e-05	477	193	12	C0005586
Disease	Brody myopathy (implicated_via_orthology)	ATP2A2 ATP2A3	1.27e-04	3	193	2	DOID:0050692 (implicated_via_orthology)
Disease	Cerebellar Ataxia	SYNE1 SNX14	4.20e-04	5	193	2	C0007758
Disease	cortical surface area measurement	TPM1 MAGI1 FILIP1 DCDC1 MYCBP2 WNT4 DYSF FGF18 FGF17 NAV1 PLCL1 ALCAM MED23 NCOA2 ACTRT2 CLSTN1 KIF20B EDEM2 PRKG1 SH3RF3	5.51e-04	1345	193	20	EFO_0010736
Disease	Digitotalar Dysmorphism	TPM2 MYBPC1	6.27e-04	6	193	2	C1852085
Disease	ARTHROGRYPOSIS, DISTAL, TYPE 1	TPM2 MYBPC1	6.27e-04	6	193	2	C0220662
Disease	retinitis pigmentosa (implicated_via_orthology)	PDE6B CRB1 SNRNP200	7.18e-04	27	193	3	DOID:10584 (implicated_via_orthology)
Disease	erythronate measurement	PTPRA CDH17	8.75e-04	7	193	2	EFO_0021025
Disease	syndromic X-linked intellectual disability Najm type (implicated_via_orthology)	CSNK1D CSNK1E	8.75e-04	7	193	2	DOID:0060807 (implicated_via_orthology)
Disease	Ovarian Mucinous Adenocarcinoma	MATK LRRK2 CDK14	1.08e-03	31	193	3	C1335167
Disease	cardiac arrest (biomarker_via_orthology)	TRPM4 ITPR1	1.16e-03	8	193	2	DOID:0060319 (biomarker_via_orthology)
Disease	aortic measurement	DCDC1 HNF4G CPQ NAV1 USP15 AP3D1 CCDC141	1.38e-03	251	193	7	EFO_0020865
Disease	Distal arthrogryposis	TPM2 MYBPC1	1.49e-03	9	193	2	cv:C0265213
Disease	plasma renin activity measurement	KNG1 XIRP2	1.49e-03	9	193	2	EFO_0006828
Disease	asthma (implicated_via_orthology)	ITGB6 ITPR1 NR3C1	1.55e-03	35	193	3	DOID:2841 (implicated_via_orthology)
Disease	Duchenne muscular dystrophy (implicated_via_orthology)	CAPN9 CTNNAL1 CACNA1C	1.68e-03	36	193	3	DOID:11723 (implicated_via_orthology)
Disease	maturity-onset diabetes of the young (implicated_via_orthology)	HNF4G HKDC1	1.85e-03	10	193	2	DOID:0050524 (implicated_via_orthology)
Disease	Schizophrenia	MAGI1 ABCA13 ITGB3 PTPRA NAV1 WNK3 GPM6A CACNA1C NR3C1 XRCC4 CSNK1E EDEM2 MTR ATP2A2	2.11e-03	883	193	14	C0036341
Disease	HYPOGONADOTROPIC HYPOGONADISM 7 WITH OR WITHOUT ANOSMIA	FGF17 CCDC141	2.25e-03	11	193	2	146110
Disease	Hypogonadotropic hypogonadism 7 with or without anosmia	FGF17 CCDC141	2.25e-03	11	193	2	cv:C0342384
Disease	congestive heart failure (implicated_via_orthology)	TOMM70 NR3C1 ATP2A2	2.45e-03	41	193	3	DOID:6000 (implicated_via_orthology)
Disease	retinitis pigmentosa (is_implicated_in)	HKDC1 CRB1 SNRNP200	2.45e-03	41	193	3	DOID:10584 (is_implicated_in)
Disease	migraine disorder	CPQ DSTN BAZ1B RNF213 NBEA NR3C1 PRKG1 PRDM16	2.53e-03	357	193	8	MONDO_0005277
Disease	volumetric bone mineral density	WNT4 CACNA1C RANBP3L	2.62e-03	42	193	3	EFO_0007620
Disease	mismatch repair cancer syndrome (is_implicated_in)	POLE ASTE1	2.69e-03	12	193	2	DOID:0112182 (is_implicated_in)
Disease	collagen disease (implicated_via_orthology)	COL4A6 TLR5	2.69e-03	12	193	2	DOID:854 (implicated_via_orthology)
Disease	age of onset of multiple sclerosis	ITPR1 CDH17	2.69e-03	12	193	2	OBA_2001029
Disease	nicotine dependence symptom count	EPHB3 MAGI1 MYCBP2 FBXL5 CACNA1C NBEA PRDM16	2.82e-03	285	193	7	EFO_0009262
Disease	severe acute respiratory syndrome, COVID-19	MAGI1 TCP11L1 DIAPH2 ALCAM NCOA2 SGTB RTF2 ODAD2 ACSF2	2.85e-03	447	193	9	EFO_0000694, MONDO_0100096
Disease	Congenital pontocerebellar hypoplasia	AMPD2 VPS53	3.17e-03	13	193	2	C0266468
Disease	Kartagener syndrome (implicated_via_orthology)	ODAD2 CCDC39	3.68e-03	14	193	2	DOID:0050144 (implicated_via_orthology)
Disease	Left ventricular noncompaction	TPM1 PRDM16	3.68e-03	14	193	2	C1960469
Disease	body weight	TPM1 TCEAL4 RABGAP1 HNF4G APOBR FGF18 ITPR1 ZMIZ2 SPDEF PLCL1 CACNA1C RGS7BP RASGRF1 BSDC1 HUWE1 CRB1 POLR3E	3.95e-03	1261	193	17	EFO_0004338
Disease	household income	PDE2A TGM5 ZMIZ2 PLCL1 GPM6A MCM9 KDM4A	4.01e-03	304	193	7	EFO_0009695
Disease	hypertension	PLCB3 RNF213 ODAD2 XRCC4 RANBP3L KDM4A PRDM16	4.23e-03	307	193	7	EFO_0000537
Disease	colorectal mucinous adenocarcinoma	PTPRA CCDC141	4.81e-03	16	193	2	EFO_0009361
Disease	Pontoneocerebellar hypoplasia	AMPD2 VPS53	4.81e-03	16	193	2	cv:C1261175
Disease	succinylcarnitine measurement	TPM1 PTPRA	4.81e-03	16	193	2	EFO_0020020
Disease	attention deficit hyperactivity disorder, autism spectrum disorder, intelligence	WNT4 DYSF NEK4 ZMIZ2 NAV1 PLCL1 METTL13 KDM4A	4.86e-03	398	193	8	EFO_0003756, EFO_0003888, EFO_0004337
Disease	coronary artery disease	CLTCL1 RRP1B DCLK2 PLCL1 ALCAM SETD9 TDRKH CD300LF RNF213 ACTRT2 AKAP12 GLMN EDEM2 PRKG1 PRDM16 CDH17	5.43e-03	1194	193	16	EFO_0001645
Disease	MAJOR AFFECTIVE DISORDER 2	MAGI1 CDH17	5.43e-03	17	193	2	C1839839
Disease	muscular dystrophy (is_implicated_in)	DYSF SYNE1	5.43e-03	17	193	2	DOID:9884 (is_implicated_in)
Disease	protein C measurement	BAZ1B EDEM2	5.43e-03	17	193	2	EFO_0004633
Disease	Night blindness, congenital stationary	PDE6B CACNA2D4	5.43e-03	17	193	2	C0339535
Disease	perinatal necrotizing enterocolitis (biomarker_via_orthology)	TLR6 TLR5	5.43e-03	17	193	2	DOID:8677 (biomarker_via_orthology)
Disease	brain volume measurement	DCDC1 WNT4 FGF18 PTPRA PLCL1 ALCAM SGTB ACTRT2 CARD11 PRDM16	6.03e-03	595	193	10	EFO_0006930
Disease	glucose homeostasis measurement, acute insulin response measurement	ATP2A2 ATP2A3	6.08e-03	18	193	2	EFO_0006831, EFO_0006896
Disease	Idiopathic hypogonadotropic hypogonadism	FGF17 CCDC141	6.08e-03	18	193	2	C0342384
Disease	urate measurement	TPM2 DCDC1 ASH1L CCDC81 DYSF HNF4G ITGB6 NAV1 PLCB3 HERC6 POLE BAZ1B CACNA2D4	6.24e-03	895	193	13	EFO_0004531

Protein segments in the cluster

Peptide	Gene	Start	Entry
ISDEILSDTIGEKKE	TMEM184C	416	Q9NVA4
KEGEGLEECSKIEVK	EPB41	171	P11171
LKDGLCLSESETVNK	ANKLE2	281	Q86XL3
SISIECKGIDKEVND	ASH1L	621	Q9NR48
VTLCLTEELAAAGEK	COL4A6	11	Q14031
IKEEIASCGDVAKAI	CPQ	36	Q9Y646
IKEAIKGVGTDEACL	ANXA11	281	P50995
DTIEKELISFCLDTK	CDNF	61	Q49AH0
CLEEKKGEISELLVG	BSDC1	151	Q9NW68
KCDTDIQKILFGEIV	ACTRT2	286	Q8TDY3
NEEGKCEVTEVSKLD	AHSA1	51	O95433
KELVKLKETCVSGED	AKAP12	461	Q02952
SLEKLKDFGECVIAL	BAZ1B	1086	Q9UIG0
TSCESIVETKGEEKV	CD300E	56	Q496F6
CEKGLVEKSAGDVDT	AGRN	1856	O00468
LVEGTSDKIQCLEKA	ANKRD30A	331	Q9BXX3
TVDNCKKLGLVFDDV	CAP1	371	Q01518
LEDDVKVSKSCQGIL	ABCA13	1186	Q86UQ4
TEKALTALLKCGAED	AARSD1	256	Q9BTE6
GEETTVEEIKAFCKG	ACSF2	561	Q96CM8
LTESKKVLEDVTGEE	API5	176	Q9BZZ5
ALKKDDTTFDEICVT	CDK14	31	O94921
GEGVIRSKEKLDCEL	CLSTN1	106	O94985
GKCKEIAEELFTRSL	AMPD2	121	Q01433
SADKKCIIVEEGKEI	DSTN	41	P60981
AVTLACEELKKSESF	DIAPH2	816	O60879
KDVTIKCGIEETLDS	DIPK1B	111	Q5VUD6
KVGEATETALTCLVE	ATP2A3	436	Q93084
VVLDGGCDISDKKLT	ASTE1	76	Q2TB18
CDAKEIKDAISGIGT	ANXA6	96	P08133
IKDAISGIGTDEKCL	ANXA6	101	P08133
VCLLVKKGENSVSVD	AP3D1	1116	O14617
LEEKKSTCGLLETQI	CCDC39	491	Q9UFE4
SEEKVLDVEKDGCVA	C16orf46	236	Q6P387
SGKSKDCVFTEIVLE	FGF17	121	O60258
KDVLFLKDCVGAEVE	PGK2	91	P07205
GTKSLDCKIEESAET	RGS7BP	161	Q6MZT1
DSSTCIGILAKEVEI	EDC4	86	Q6P2E9
EEVLLEKKGCTGVIT	HIBCH	36	Q6NVY1
SGDVSKECAEKILET	RABGAP1	526	Q9Y3P9
FKVISVAEVDLSCDK	DCDC1	1361	M0R2J8
VAEVDLSCDKAEKTL	DCDC1	1366	M0R2J8
KGDVVTILEACENKS	MATK	71	P42679
LVTDDLTDAIICAKK	LYZL2	101	Q7Z4W2
VLGVIDSCKEAVTFK	MAGI1	86	Q96QZ7
VFVCDEDATLELKVK	GNPDA1	236	P46926
KGAKSLVELLDESEC	GGNBP2	621	Q9H3C7
VGKREFSCVALEKEE	INMT	206	O95050
KEEILKTTCFICGLE	ITPR1	2611	Q14643
GELVTASTTCEKLEK	MTUS1	966	Q9ULD2
EGEKVKAEISFVLCK	EIF1AD	76	Q8N9N8
DVCISLEIDDLKKIT	EIF3J	186	O75822
GEEKKICTVSENFLR	GPM6A	186	P51674
KDSCIIKEGDVGSLV	PRKG1	126	Q13976
AVVKECIDRSTGKEF	DCLK2	406	Q8N568
AVESIEKISKVECGF	EDEM2	396	Q9BV94
EIKSLDEQCVVGKIS	PLSCR1	246	O15162
VDKCKLAGATISEEE	ITGB6	646	P18564
CKVIGDKVLGEEVSF	PDE2A	276	O00408
EEERVAAKKVGTEIC	PDE6B	826	P35913
LKLDSKESCEDVPVA	NEK4	716	P51957
AGEEVAIKLECVKTK	CSNK1D	31	P48730
DGTSKECVFIEKVLE	FGF18	121	O76093
ALETLIVDLVSCGKE	HERC6	71	Q8IVU3
IFKDLVGKCDTREEA	KIF20B	641	Q96Q89
EDEKTKLISCLGAFR	MED23	31	Q9ULK4
YLEEDGTSILVSCKK	KDM4A	726	O75164
LEIDICGEGETLLKK	LRRK2	1796	Q5S007
EGTELIGKKKTICES	SELL	291	P14151
KEIDVSCVKIEEVIG	EPHB3	626	P54753
VIFSLEELKEIEKDC	TUBGCP6	626	Q96RT7
VKTEKEDFIELCTPG	NR3C1	276	P04150
FEEVCDEIKSKLASL	POLE	596	Q07864
DREEICGKKSTCVLE	PCDHGB3	91	Q9Y5G1
KDKDVESKSQCIEGI	PACS2	821	Q86VP3
SSVCVGREDDIKKSE	RFESD	16	Q8TAC1
TEKETSLEETKIGEI	HUWE1	1731	Q7Z6Z7
KSLSELTFDEIVCKI	DZIP3	1066	Q86Y13
TDINVKKIASIGDVC	HNF4G	126	Q14541
CDKLAVEETKGELLL	NAA15	221	Q9BXJ9
VKGLSEDTTEETLKE	NCL	576	P19338
ADKKRVETALESCGL	PLCB3	181	Q01970
DGEVSCKEATSIKRV	QTRT2	146	Q9H974
VKTDTGKESCDVVLL	PIKFYVE	1961	Q9Y2I7
VVSCLEKGLVKEAEE	GLG1	266	Q92896
KVGEATETALTCLVE	ATP2A2	436	P16615
EDKETKVDTTVVFDC	IGSF22	241	Q8N9C0
IRVSITEKCAKEFGE	PRKACB	336	P22694
VTKKDLKVCVEFDGE	KDM3A	56	Q9Y4C1
ELTEVCKSLGKVFGV	BLM	1221	P54132
KHKEVLESVTELCES	CCDC141	1096	Q6ZP82
EEKIELKSITADGES	CACNA1C	801	Q13936
KLGLLTSDADCEIEK	CTNNAL1	571	Q9UBT7
DVVEGCVKETLLFLS	CCDC81	121	Q6ZN84
KDVESSLKIEEVDGL	CACNA2D4	106	Q7Z3S7
DCKILVKTSGSEQEV	CD300LF	61	Q8TDQ1
ETLTETKIHCETDEK	DDX24	561	Q9GZR7
CRDEIESVKELKDTG	ITGB3	661	P05106
EDLEDCSVLTTLLKG	ACOD1	446	A6NK06
LTESCETKKLGQSLD	KNG1	336	P01042
SGCEKITDVALEKIS	FBXL5	391	Q9UKA1
SILVDFEEASGKKIC	CCDC158	191	Q5M9N0
CEASIKSITVDENGK	ERCC6L2	46	Q5T890
EAVTLTLIDDSCKEK	CRB1	576	P82279
KGTLDAVLTDEEEKT	METTL13	121	Q8N6R0
TIEVSDKDFKTLCFV	CDH17	421	Q12864
KLSLTEKDEGQEECS	CAPN9	381	O14815
GLTDEICKDYSIVKE	PIWIL3	406	Q7Z3Z3
VATVTKLCAEDVKDF	POLR3E	371	Q9NVU0
LETEQLKKLGDCISE	ALCAM	146	Q13740
DLLSKDEKIGETVVD	DYSF	1651	O75923
LEEKEDLELKCSTLG	CARD11	341	Q9BXL7
CFIKKDSTLDAAEEI	KYAT3	431	Q6YP21
LFSIVEEETGKDCAK	OTOF	871	Q9HC10
EEETGKDCAKVKTLF	OTOF	876	Q9HC10
GASEKETELEFLKVC	PTPN13	756	Q12923
GDITVELKKEEECES	PTPRA	656	P18433
KISDFGCSEKLEDLL	MOS	216	P00540
KVILEDDLVDSCKSG	MCM9	221	Q9NXL9
GLKEKCVDSLVFETL	NAV1	1521	Q8NEY1
QKSKDLCSITVSGEE	GLMN	531	Q92990
GCVFSERALKEIKAE	RTF2	141	Q9BY42
DVLTTIGEKVCLEVS	TCP11L1	391	Q9NUJ3
LEKEKGSRVFCVEEE	RRP1B	376	Q14684
KLLTSAIGETVTECE	SYNE1	4866	Q8NF91
VNAEGTDCLEAKEKV	SYNE1	8621	Q8NF91
EGKDEEITKTESQCR	FILIP1	391	Q7Z7B0
VKELGKEEGEILASC	FER1L5	1191	A0AVI2
LGLDSTCEDSIVVKE	HKDC1	806	Q2TB90
DLAGVETCKSLESQK	LCMT1	251	Q9UIC8
IDCGVLATKSIKDVF	NKTR	171	P30414
EKEDTIVDGTSKCEE	PUS7L	106	Q9H0K6
IVDGTSKCEEKADVL	PUS7L	111	Q9H0K6
NLLETDEVKCKIGSL	ODAD2	501	Q5T2S8
LTCTSSIIEEKEFKI	NBEA	1196	Q8NFP9
EGCITKISEDLGSEK	PRDM16	141	Q9HAZ2
IADADVGLKSIVKEC	GIMAP7	146	Q8NHV1
KCIVNSISLKEGEDD	MTR	466	Q99707
GCTAEETLEALILKE	POLR3A	741	O14802
ESKDKVISDEDVLGT	SETD9	41	Q8NE22
KVGIEDICEEIKVVS	SLCO6A1	201	Q86UG4
VKKLGGTIDDCELVE	CCT4	211	P50991
AVVEETSKLAECIGK	MYCBP2	1486	O75592
EVTQIKCIELKSELG	P2RY14	166	Q15391
TNDELKCKVIGFLEE	RASGRF1	971	Q13972
TKQDCETLLLKEGVD	SH2D1B	11	O14796
LSDLEAKCEKVSEFV	ABTB1	201	Q969K4
EEETCAKTLGEHIIK	AKAP3	441	O75969
KGEEVVVVEKACEST	APOBR	246	Q0VD83
KLECSEELGDLVKSV	CLTC	456	Q00610
KLECSEELGDLVKTT	CLTCL1	456	P53675
CLKEGSTLLQIESKE	CLEC9A	141	Q6UXN8
EALTEEKEITISKCS	C12orf50	216	Q8NA57
KSIKEEGEDLQSCLI	NCOA2	236	Q15596
IEELILGKCDISSEV	NLRP9	716	Q7RTR0
IDEILEKTESSVCKE	STK31	551	Q9BXU1
EKTESSVCKELEIAL	STK31	556	Q9BXU1
IKESQEGDECVKTVT	XIRP2	1076	A4UGR9
GLEDSVAKTFEKCII	RNF213	986	Q63HN8
EVTCTLEDKKLENEG	TCEAL4	31	Q96EI5
KEKLTTRVTEEEFCE	PLCL1	291	Q15111
GDCKKLTSEIFAEIE	USPL1	291	Q5W0Q7
SICTDETGIEQLKKE	ZDHHC3	241	Q9NYG2
AKITCDKESEGTLLL	TDRKH	156	Q9Y2W6
LLVKCIGEETKYESI	SNX14	886	Q9Y5W7
TAEEKTITEKHLELC	SPIDR	66	Q14159
EKVVAKEDSEKTCEV	SPIDR	386	Q14159
KDCLTFTKDEILTVL	SH3RF3	276	Q8TEJ3
VVGEVLKDIETACKL	SPDEF	126	O95238
KCLLEKIDVITGEET	RANBP3L	281	Q86VV4
EKDIKQEGETAICSE	XRCC4	206	Q13426
DECGKTFILRKTLNE	ZNF660	221	Q6AZW8
CIELFTTKEKLGAED	USP15	791	Q9Y4E8
IKEKLFSLGCTEEEV	MTERF1	296	Q99551
DKIISECSKEIDAEG	TOMM70	311	O94826
KEECFGLTAELVVDK	PRPF38A	36	Q8NAV1
SNEGVIEIKATKVCD	RFX7	486	Q2KHR2
KGDFETIKICDVGVS	PBK	176	Q96KB5
EDCVLTVEGSGLFKK	TGM5	651	O43548
KEGSEVAKFTLEELC	VPS53	536	Q5VIR6
TDSIFEKCSTLVKLE	TLR6	366	Q9Y2C9
EDGVEQTAIKVSLKC	ZMIZ2	586	Q8NF64
IKRCTDKGVESVFDI	SNRNP200	1971	O75643
SEGKCAELEEELKTV	TPM1	186	P09493
LELKKGCESVDEGKV	ZNF90	111	Q03938
SISEEETCEKLKGLI	WNT4	36	P56705
TDAIKDCEKAIAIDS	SGTB	136	Q96EQ0
GETLDKAVCSLQKET	TASOR2	1131	Q5VWN6
GECIEDITNKFKEID	ZCWPW2	336	Q504Y3
ILEDELEKLVCTKET	VEZT	446	Q9HBM0
KTTEKLCESEEAGVI	TTC39C	91	Q8N584
TEGCDEEEVLKSLKF	TLR5	626	O60602
AESKCGDLEEELKIV	TPM2	186	P07951
KCTESEEEEVTKGKE	USP14	256	P54578
EEFETIVLKALVKAC	TRPM4	371	Q8TD43
VITAAECLKEEGKTS	ZFYVE16	286	Q7Z3T8
FKITCGKVDAVDLRE	ZFYVE16	1366	Q7Z3T8
LEADFETDEKIVKCT	ZFYVE16	1416	Q7Z3T8
VEEKESEKCVKEGVT	TTLL13	16	A6NNM8
VVDGKISECASVETK	WNK3	941	Q9BYP7
SGEEVAIKLECVKTK	CSNK1E	31	P49674
TDLIKVKLTLEEEAC	LDHAL6A	301	Q6ZMR3
TETDKDIAPVLDLKC	L1TD1	31	Q5T7N2
GTVEIECKLEVKVIA	MYBPC1	1126	Q00872